Check out Louise Zornoza’s recent coverage of a new guidance for Health Canada on raps.org . The new guidance released on April 4, 2014 covers new design and format requirements on monographs. The changes are intended to emphasize clinical relevance and make information easier to access. It will also provide format and information consistency from the various kinds of drugs and drug classes. To read the full article click here.
Obstacles Facing Biosimilars
Still in its infancy in the U.S., the industry faces some growing pains.
Life Science Accelerated
Our experts are dedicated to expediting life science product development regulatory pathways.